Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma

Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma

BackgroundTo compare the testing costs and testing turnaround times of tissue-first, plasma-first, and complementary next-generation sequencing (NGS) approaches in patients with treatment-naïve metastatic lung adenocarcinoma.Materials and MethodsWe developed a decision tree model to compare three di...

Full description

Bibliographic Details
Main Authors: Szu-Chun Yang, Chien-Chung Lin, Yi-Lin Chen, Wu-Chou Su
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
liquid biopsy
ctDNA
next-generation sequencing
cost analysis
cost minimization
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.873111/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.873111/full

Similar Items